Medicines Discovery Catapult
Overview
Medicines Discovery Catapult is a not-for-profit, government-supported organization that reshapes drug discovery for patient benefit by transforming UK science into better treatments through partnership.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| PhalconBio GmbH | Feb 2025 | Grant | Co-investor |
| Rostra Therapeutics | Nov 2024 | Grant | Co-investor |
| Centauri Therapeutics Limited | Nov 2024 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Medicines Discovery Catapult based?
Medicines Discovery Catapult is headquartered in Macclesfield, United Kingdom.
When was Medicines Discovery Catapult founded?
Medicines Discovery Catapult was founded in 2015.
How many portfolio companies does Medicines Discovery Catapult have?
Medicines Discovery Catapult has 3 portfolio companies in Caplight's dataset.
What are some companies in Medicines Discovery Catapult's portfolio?
Portfolio companies visible on Caplight include PhalconBio GmbH, Rostra Therapeutics, Centauri Therapeutics Limited.
What was Medicines Discovery Catapult's most recent investment shown here?
Medicines Discovery Catapult's most recent investment in this portfolio sample was in PhalconBio GmbH in 2025.
What sectors does Medicines Discovery Catapult focus on?
Medicines Discovery Catapult focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Medicines Discovery Catapult focus on?
Stage focus information for Medicines Discovery Catapult is not publicly available.